Abstract | BACKGROUND: CASE REPORT: We present the case of a 53-year-old male patient with tumor metastases which developed after radical nephrectomy. We describe the immunohistochemistry profile of the tumor and the successful long-term results of treatment with sunitinib, a multi-targeted tyrosine kinase inhibitor. Also, we discuss the rationale for using this type of medication based on immunohistochemistry results. CONCLUSION:
|
Authors | Yuri Tolkach, Sergey Petrov, Evelyne Lerut, Hendrik Van Poppel |
Journal | Onkologie
(Onkologie)
Vol. 35
Issue 6
Pg. 376-8
( 2012)
ISSN: 1423-0240 [Electronic] Switzerland |
PMID | 22722460
(Publication Type: Case Reports, Journal Article)
|
Copyright | Copyright © 2012 S. Karger AG, Basel. |
Chemical References |
- Angiogenesis Inhibitors
- Antineoplastic Agents
- Indoles
- Pyrroles
- Sunitinib
|
Topics |
- Angiogenesis Inhibitors
(therapeutic use)
- Antineoplastic Agents
(therapeutic use)
- Hemangioendothelioma, Epithelioid
(diagnosis, drug therapy)
- Humans
- Indoles
(therapeutic use)
- Kidney Neoplasms
(diagnosis, drug therapy)
- Male
- Middle Aged
- Pyrroles
(therapeutic use)
- Sunitinib
- Treatment Outcome
|